Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-07 Sale | 2025-03-10 6:43 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 6,669 | $11.97 | $79,828 | 475,312 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 8:37 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,394 | $10.02 | $23,988 | 267,940 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 8:36 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,918 | $10.02 | $19,218 | 194,577 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 8:47 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,601 | $9.8242 | $25,553 | 108,906 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 8:46 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 3,125 | $9.8242 | $30,701 | 124,512 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 8:46 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 5,104 | $9.8242 | $50,143 | 311,783 (Direct) | View |
| 2025-02-12 Purchase | 2025-02-14 7:45 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 161,700 | $9.2682 | $1,498,661 | 5,278,985 (Indirect) | View |
| 2025-02-07 Purchase | 2025-02-11 7:51 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 104,489 | $9.2559 | $967,145 | 5,117,285 (Indirect) | View |
| 2025-01-30 Purchase | 2025-02-03 7:42 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 70,023 | $8.8775 | $621,628 | 5,012,796 (Indirect) | View |
| 2024-12-09 Sale | 2024-12-09 9:08 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,627 | $9.75 | $74,363 | 477,722 (Direct) | View |
| 2024-11-26 Sale | 2024-11-27 8:45 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,187 | $9.8702 | $21,586 | 167,012 (Direct) | View |
| 2024-11-26 Sale | 2024-11-27 8:43 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,963 | $9.8718 | $19,378 | 134,892 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:19 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 14,400 | $9.2565 | $133,294 | 308,889 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 7,192 | $9.2565 | $66,573 | 110,345 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:18 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 8,077 | $9.2566 | $74,766 | 124,824 (Direct) | View |
| 2024-09-09 Sale | 2024-09-10 8:31 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,352 | $12.19 | $89,622 | 469,551 (Direct) | View |
| 2024-08-23 Sale | 2024-08-26 8:00 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,135 | $12.4 | $26,474 | 158,745 (Direct) | View |
| 2024-08-23 Sale | 2024-08-26 7:58 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,916 | $12.4 | $23,758 | 132,551 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 9:26 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 7,973 | $12.01 | $95,782 | 130,036 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 9:25 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 14,215 | $12.01 | $170,769 | 315,016 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 9:25 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 7,102 | $12.01 | $85,318 | 116,328 (Direct) | View |
| 2024-06-07 Sale | 2024-06-10 6:42 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,465 | $11.53 | $86,068 | 458,922 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:59 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 8,088 | $11.76 | $95,151 | 116,214 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:58 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 13,175 | $11.76 | $154,997 | 138,009 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:57 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 21,959 | $11.76 | $258,337 | 319,071 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:55 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 11,610 | $11.76 | $136,586 | 123,430 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-06 Exercise | 2025-03-10 6:43 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 475,312 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 8:37 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 267,940 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:37 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 100,000 | $0 | 267,940 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 372,000 | $0 | 372,000 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 194,577 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 60,000 | $0 | 194,577 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:35 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2025-02-17 Exercise | 2025-02-19 8:47 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 8,408 | $0 | 108,906 (Direct) | View |
| 2025-02-17 Exercise | 2025-02-19 8:46 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 12,894 | $0 | 124,512 (Direct) | View |
| 2025-02-17 Exercise | 2025-02-19 8:46 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 18,726 | $0 | 311,783 (Direct) | View |
Ownership | 2025-02-03 7:39 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner | 0 | $0 | 5,598,511 (Indirect) | View |
| 2024-12-06 Exercise | 2024-12-09 9:08 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 477,722 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-27 8:45 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 167,012 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-27 8:43 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 134,892 (Direct) | View |
| 2024-11-23 Option Award | 2024-11-26 4:41 pm | N/A 2034-11-22 | KalVista Pharmaceuticals Inc. | KALV | Reid Laurence Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:19 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 60,396 | $0 | 308,889 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 22,992 | $0 | 110,345 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 37,062 | $0 | 124,824 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:08 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Fairey William Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:08 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:07 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:07 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:06 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-09-09 Option Award | 2024-09-11 4:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-09-06 Exercise | 2024-09-10 8:31 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 469,551 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-26 8:00 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 158,745 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-26 7:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 132,551 (Direct) | View |
| 2024-08-17 Exercise | 2024-08-21 9:26 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 37,056 | $0 | 130,036 (Direct) | View |
| 2024-08-17 Exercise | 2024-08-21 9:25 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 60,390 | $0 | 315,016 (Direct) | View |
| 2024-08-17 Exercise | 2024-08-21 9:25 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 22,990 | $0 | 116,328 (Direct) | View |
| 2024-06-06 Exercise | 2024-06-10 6:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 458,922 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 4:10 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 4:08 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 80,000 | $0 | 80,000 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 5:59 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 37,578 | $0 | 116,214 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-21 5:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 61,228 | $0 | 138,009 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 5:57 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 102,062 | $0 | 319,071 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 5:55 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 37,578 | $0 | 123,430 (Direct) | View |